• Real-time Molecule Monitoring Could Put an End to ‘Reactive Medicine’

    Jun 17 | Diagnostics World | Modern jet engines can generate a terabyte or more of data per hour that gets transmitted back to the engine manufacturer to ensure aircraft safety and prevent disasters from happening. Yet the human body, arguably the most important machinery of them all, gets checked only once a year or whenever something has already gone wrong. More

  • Myeloma Diagnostics: Ultra-Sensitive Detection and Population-Scale Screening Transform Disease Management

    Jun 12 | Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics. More

  • Pharmacogenomic Testing Shows Value in Improving Prescribing Precision

    Jun 11 | Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice. More

  • Endometriosis Developments: Newly Launched Tests and Treatment Updates

    Jun 10 | Diagnostics World | Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. The condition is painful, can impede fertility, and is difficult to diagnose. But a host of new tools seek to improve diagnostics and treatment for the condition. More

  • Genetic Diagnostics Find Common Ground Between ME/CFS, Long COVID

    Jun 05 | Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations. More

  • After More Than Four Decades, a Third Subtype of Castleman Disease Found

    Jun 03 | Diagnostics World | A new subtype of Castleman disease has been identified, the first such major discovery in 45 years. While it remains unclear how many individuals stand to benefit, this is a “hugely important” development for the proportion of patients who fit neither the “unicentric” nor “multicentric” criteria long used to describe the symptoms and disease experience. More

  • Follow the Money: Deepull’s Diagnostic System, Gestalt Expands Pathology Platform, More

    May 30 | Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more. More

  • Microsoft, iCAD Collaboration, Revvity Launches New Platform, More

    May 29 | Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more. More

  • Smart Bandage for Monitoring Chronic Wounds Moves from Mice to Humans

    May 27 | Diagnostics World | Parallel developments in wearable sensors, microfluidics, and machine learning have enabled the first-time use of a “smart bandage” in 20 human patients with chronic wounds. The latest version of the bandage, referred to as iCares, was showcased in a new study where fresh fluid from injured tissue was continually sampled to classify wound severity and healing potential. More

  • The Diagnostic Dilemma: Addressing Errors in Modern Healthcare

    May 23 | Diagnostics World | Diagnostic errors remain a persistent and costly challenge in healthcare worldwide, leading to significant patient harm and financial burden. Despite advances in medical technology and research, these errors—missed, delayed, or incorrect diagnoses—cause thousands of preventable deaths and billions in healthcare costs each year. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more